Literature DB >> 19183911

[Historical aspects concerning the symptom of itch in the German-speaking region (1850-1939)].

E Weisshaar1, V Grüll, T L Diepgen, W U Eckart.   

Abstract

Since the establishment of dermatology as an independent discipline of medicine in the middle of the 19th century, pruritus or itch has been a subject of research. The goals were to discover the etiology of pruritus, to develop useful therapies and to achieve a classification within the system of skin diseases. Looking at historical aspects of pruritus demonstrates just how difficult it has been to approach this problem. The difficulties even influence present day pruritus research. For example, there is no definite international standard of pruritus. Etiology-oriented classifications have dominated, but have recently been supplemented by a clinical classification.

Entities:  

Mesh:

Year:  2009        PMID: 19183911     DOI: 10.1007/s00105-008-1691-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

Review 1.  [Diagnostic and therapeutic procedures in chronic pruritus].

Authors:  Sonja Ständer; Markus Streit; Ulf Darsow; Volker Niemeier; Maria Vogelgsang; Hartmut Ständer; Uwe Gieler; Harald Gollnick; Dieter Metze; Elke Weisshaar
Journal:  J Dtsch Dermatol Ges       Date:  2006-04       Impact factor: 5.584

2.  [About Itching and scabies. Pruritus in medical history--from ancient world to the French revolution].

Authors:  E Weisshaar; A König; T L Diepgen; W U Eckart
Journal:  Hautarzt       Date:  2008-12       Impact factor: 0.751

Review 3.  [Clinical classification of chronic pruritus. Interdisciplinary consensus proposal for a diagnostic algorithm].

Authors:  S Ständer; E Weisshaar; T Mettang; M Streit; U Darsow; G Schneider; D Metze; M Schmelz
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

  3 in total
  1 in total

1.  [Dermato-epidemiology].

Authors:  C J Apfelbacher; T L Diepgen; E Weisshaar
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.